Cargando…
Tisochrysis lutea F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling
Pre-metabolic syndrome (pre-MetS) may represent the best transition phase to start treatments aimed at reducing cardiometabolic risk factors of MetS. In this study, we investigated the effects of the marine microalga Tisochrysis lutea F&M-M36 (T. lutea) on cardiometabolic components of pre-MetS...
Autores principales: | D’Ambrosio, Mario, Bigagli, Elisabetta, Cinci, Lorenzo, Gencarelli, Manuela, Chioccioli, Sofia, Biondi, Natascia, Rodolfi, Liliana, Niccolai, Alberto, Zambelli, Francesca, Laurino, Annunziatina, Raimondi, Laura, Tredici, Mario R., Luceri, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222845/ https://www.ncbi.nlm.nih.gov/pubmed/37233497 http://dx.doi.org/10.3390/md21050303 |
Ejemplares similares
-
A Comparative In Vitro Evaluation of the Anti-Inflammatory Effects of a Tisochrysis lutea Extract and Fucoxanthin
por: Bigagli, Elisabetta, et al.
Publicado: (2021) -
Tisochrysis lutea as a Substrate for Lactic Acid Fermentation: Biochemical Composition, Digestibility, and Functional Properties
por: Pagnini, Caterina, et al.
Publicado: (2023) -
Thyroid Hormone, Thyroid Hormone Metabolites and Mast Cells: A Less Explored Issue
por: Landucci, Elisa, et al.
Publicado: (2019) -
Recovery of Water-Soluble Compounds from Tisochrysis lutea
por: Lina, Robin, et al.
Publicado: (2022) -
Effect of cultivation mode on the production of docosahexaenoic acid by Tisochrysis lutea
por: Hu, Hao, et al.
Publicado: (2018)